Natera, Inc. (NTRA)
NASDAQ
Real-time Data
01:30 PM
Day's Range
380.3952 wk Range
167.99Overview - NTRA - Natera, Inc.
Key Statistics
Valuation
Enterprise Value
58.29B
P/E (Trailing)
‪-269.83‬
P/E (Forward)
‪-2,989.14‬
PEG Ratio
‪7.39‬
Price / Sales (TTM)
‪21.84‬
Price / Book
‪32.35‬
EV / EBITDA
‪-259.76‬
Profitability
Gross Margin
‪64.45%‬
Profit Margin
‪-7.10%‬
Operating Margin
‪-10.29%‬
Return on Assets
‪-8.07%‬
Return on Equity
‪-12.54%‬
Ownership
Shares Outstanding
143.61M
Float
140.11M
Short % of Shares Outstanding
‪3.43%‬
Held by Insiders
‪2.81%‬
Held by Institutions
‪96.73%‬
Price stats
Beta
‪1.53‬
50-Day Avg
‪331.07‬
200-Day Avg
‪249.05‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
23 analysts
Average price target
‪$ 336.74‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - NTRA - Natera, Inc.
Peers - NTRA - Natera, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- NTRANASDAQNatera, Inc.59.14BMarket Cap+58.48%52-week change-269.84P/E (Trailing)‪-7.10%‬Profit Margin
- ILMNNASDAQIllumina Inc.41.22BMarket Cap+63.00%52-week change50.85P/E (Trailing)‪18.33%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.40.83BMarket Cap-21.10%52-week change37.14P/E (Trailing)‪25.03%‬Profit Margin
- GHNASDAQGuardant Health Inc.23.86BMarket Cap+64.35%52-week change-53.55P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings, Inc.16.86BMarket Cap+14.16%52-week change35.48P/E (Trailing)‪17.66%‬Profit Margin
- ICLRNASDAQICON plc12.50BMarket Cap-17.51%52-week change170.58P/E (Trailing)‪0.32%‬Profit Margin
- TWSTNASDAQTwist Bioscience Corporation12.12BMarket Cap+85.23%52-week change-140.79P/E (Trailing)‪-31.66%‬Profit Margin
Profile Summary - NTRA - Natera, Inc.
About
Natera, Inc. is a molecular diagnostics company that develops and commercializes cell-free DNA and genetic testing services for clinical use. The company focuses on oncology, women’s health, and organ health, using proprietary molecular assays and bioinformatics to help detect and monitor genetic conditions and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
